{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Cancer", "ETS family", "Erythropoiesis", "FLI1", "Hematopoiesis", "Leukemia", "Megakaryopoiesis"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35412146", "DateCompleted": {"Year": "2022", "Month": "04", "Day": "14"}, "DateRevised": {"Year": "2024", "Month": "05", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "02", "Day": "28"}], "Language": ["eng"], "ELocationID": ["163", "10.1007/s00018-022-04160-1"], "Journal": {"ISSN": "1420-9071", "JournalIssue": {"Volume": "79", "Issue": "3", "PubDate": {"Year": "2022", "Month": "Feb", "Day": "28"}}, "Title": "Cellular and molecular life sciences : CMLS", "ISOAbbreviation": "Cell Mol Life Sci"}, "ArticleTitle": "Current insights into the role of Fli-1 in hematopoiesis and malignant transformation.", "Pagination": {"StartPage": "163", "MedlinePgn": "163"}, "Abstract": {"AbstractText": ["Fli-1, a member of the ETS family of transcription factors, was discovered in 1991 through retroviral insertional mutagenesis as a driver of mouse erythroleukemias. In the past 30\u00a0years, nearly 2000 papers have defined its biology and impact on normal development and cancer. In the hematopoietic system, Fli-1 controls self-renewal of stem cells and their differentiation into diverse mature blood cells. Fli-1 also controls endothelial survival and vasculogenesis, and high and low levels of Fli-1 are implicated in the auto-immune diseases systemic lupus erythematosus and systemic sclerosis, respectively. In addition, aberrant Fli-1 expression is observed in, and is essential for, the growth of multiple hematological malignancies and solid cancers. Here, we review the historical context and latest research on Fli-1, focusing on its role in hematopoiesis, immune response, and malignant transformation. The importance of identifying Fli-1 modulators (both agonists and antagonists) and their potential clinical applications is discussed."], "CopyrightInformation": "\u00a9 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG."}, "AuthorList": [{"Identifier": ["0000-0002-9020-6074"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Province Science City, High Tech Zone, Baiyun District, Guiyang, 550014, Guizhou Province, People's Republic of China. yaacovbendavid@hotmail.com."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province, Chinese Academic of Sciences, Guiyang, 550014, Guizhou Province, People's Republic of China. yaacovbendavid@hotmail.com."}], "LastName": "Ben-David", "ForeName": "Yaacov", "Initials": "Y"}, {"Identifier": ["0000-0001-5764-581X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Province Science City, High Tech Zone, Baiyun District, Guiyang, 550014, Guizhou Province, People's Republic of China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province, Chinese Academic of Sciences, Guiyang, 550014, Guizhou Province, People's Republic of China."}, {"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, 550025, Guizhou Province, People's Republic of China."}], "LastName": "Gajendran", "ForeName": "Babu", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Province Science City, High Tech Zone, Baiyun District, Guiyang, 550014, Guizhou Province, People's Republic of China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province, Chinese Academic of Sciences, Guiyang, 550014, Guizhou Province, People's Republic of China."}], "LastName": "Sample", "ForeName": "Klarke M", "Initials": "KM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, University of Toronto, Toronto, ON, Canada."}, {"Identifier": [], "Affiliation": "Toronto General Research Institute, Max Bell Research Centre, University Health Network, 101 College Street, Toronto, ON, Canada."}], "LastName": "Zacksenhaus", "ForeName": "Eldad", "Initials": "E"}], "GrantList": [{"GrantID": "U1812403", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "21867009", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "QKHPTRC[2019]5627", "Agency": "Guizhou Science and Technology Department", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Cell Mol Life Sci", "NlmUniqueID": "9705402", "ISSNLinking": "1420-682X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Proto-Oncogene Protein c-fli-1"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Cell Differentiation"}, {"QualifierName": ["genetics"], "DescriptorName": "Cell Transformation, Neoplastic"}, {"QualifierName": ["genetics"], "DescriptorName": "Hematopoiesis"}, {"QualifierName": ["pathology"], "DescriptorName": "Leukemia, Erythroblastic, Acute"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Proto-Oncogene Protein c-fli-1"}], "CoiStatement": "The authors declare that there are no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Friend C. Cell-free transmission in adult Swiss mice of a disease having the character of a leukemia. J Exp Med. 1957;105:307\u2013318. doi: 10.1084/jem.105.4.307.", "ArticleIdList": ["10.1084/jem.105.4.307", "PMC2136697", "13416470"]}, {"Citation": "Howard JC, Yousefi S, Cheong G, et al. Temporal order and functional analysis of mutations within the Fli-1 and p53 genes during the erythroleukemias induced by F-MuLV. Oncogene. 1993;8:2721\u20132729.", "ArticleIdList": ["8378083"]}, {"Citation": "Ben-David Y, Giddens EB, Bernstein A. Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus. Proc Natl Acad Sci USA. 1990;87:1332\u20131336. doi: 10.1073/pnas.87.4.1332.", "ArticleIdList": ["10.1073/pnas.87.4.1332", "PMC53469", "2304901"]}, {"Citation": "Ben-David Y, Giddens EB, Letwin K, et al. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Dev. 1991;5:908\u2013918. doi: 10.1101/gad.5.6.908.", "ArticleIdList": ["10.1101/gad.5.6.908", "2044959"]}, {"Citation": "Truong AH, Ben-David Y. The role of Fli-1 in normal cell function and malignant transformation. Oncogene. 2000;19(55):6482\u20136489. doi: 10.1038/sj.onc.1204042.", "ArticleIdList": ["10.1038/sj.onc.1204042", "11175364"]}, {"Citation": "Ben-David Y, Prideaux VR, Chow V, et al. Inactivation of the p53 oncogene by internal deletion or retroviral integration in erythroleukemic cell lines induced by Friend leukemia virus. Oncogene. 1988;3:179\u2013185.", "ArticleIdList": ["2842714"]}, {"Citation": "Delattre O, Zucman J, Plougastel B, et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature. 1992;359:162\u2013165. doi: 10.1038/359162a0.", "ArticleIdList": ["10.1038/359162a0", "1522903"]}, {"Citation": "May WA, Gishizky ML, Lessnick SL, et al. Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc Natl Acad Sci USA. 1993;90:5752\u20135756. doi: 10.1073/pnas.90.12.5752.", "ArticleIdList": ["10.1073/pnas.90.12.5752", "PMC46800", "8516324"]}, {"Citation": "Im YH, Kim HT, Lee C, et al. EWS-FLI1, EWS-ERG, and EWS-ETV1 oncoproteins of Ewing tumor family all suppress transcription of transforming growth factor beta type II receptor gene. Can Res. 2000;60:1536\u20131540.", "ArticleIdList": ["10749119"]}, {"Citation": "Li Y, Luo H, Liu T, et al. The ets transcription factor Fli-1 in development, cancer and disease. Oncogene. 2015;34:2022\u20132031. doi: 10.1038/onc.2014.162.", "ArticleIdList": ["10.1038/onc.2014.162", "PMC5028196", "24909161"]}, {"Citation": "Orkin SH, Zon LI. Hematopoiesis: an evolving paradigm for stem cell biology. Cell. 2008;132:631\u2013644. doi: 10.1016/j.cell.2008.01.025.", "ArticleIdList": ["10.1016/j.cell.2008.01.025", "PMC2628169", "18295580"]}, {"Citation": "De Graaf CA, Choi J, Baldwin TM, et al. Haemopedia: an expression atlas of murine hematopoietic cells. Stem Cell Rep. 2016;7:571\u2013582. doi: 10.1016/j.stemcr.2016.07.007.", "ArticleIdList": ["10.1016/j.stemcr.2016.07.007", "PMC5031953", "27499199"]}, {"Citation": "Choi J, Baldwin TM, Wong M, et al. Haemopedia RNA-seq: a database of gene expression during haematopoiesis in mice and humans. Nucleic Acids Res. 2019;47:D780\u2013D785. doi: 10.1093/nar/gky1020.", "ArticleIdList": ["10.1093/nar/gky1020", "PMC6324085", "30395284"]}, {"Citation": "Badwe CR, Lis R, Barcia Dur\u00e1n JG, et al. Fli1 is essential for the maintenance of hematopoietic stem cell homeostasis and function. Blood. 2017;130:3769. doi: 10.1182/blood.V130.Suppl_1.3769.3769.", "ArticleIdList": ["10.1182/blood.V130.Suppl_1.3769.3769"]}, {"Citation": "Hart A, Melet F, Grossfeld P, et al. Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Immunity. 2000;13:167\u2013177. doi: 10.1016/s1074-7613(00)00017-0.", "ArticleIdList": ["10.1016/s1074-7613(00)00017-0", "10981960"]}, {"Citation": "Zhao H, Zhao Y, Li Z, et al. FLI1 and PKC co-activation promote highly efficient differentiation of human embryonic stem cells into endothelial-like cells. Cell Death Dis. 2018;9:131. doi: 10.1038/s41419-017-0162-9.", "ArticleIdList": ["10.1038/s41419-017-0162-9", "PMC5833666", "29374149"]}, {"Citation": "Liu T, Yao Y, Zhang G, et al. A screen for Fli-1 transcriptional modulators identifies PKC agonists that induce erythroid to megakaryocytic differentiation and suppress leukemogenesis. Oncotarget. 2017;8:16728\u201316743. doi: 10.18632/oncotarget.14377.", "ArticleIdList": ["10.18632/oncotarget.14377", "PMC5369997", "28052010"]}, {"Citation": "Kruse EA, Loughran SJ, Baldwin TM, et al. Dual requirement for the ETS transcription factors Fli-1 and Erg in hematopoietic stem cells and the megakaryocyte lineage. Proc Natl Acad Sci USA. 2009;106:13814\u201313819. doi: 10.1073/pnas.0906556106.", "ArticleIdList": ["10.1073/pnas.0906556106", "PMC2728977", "19666492"]}, {"Citation": "Ben-David Y, Bernstein A. Friend virus-induced erythroleukemia and the multistage nature of cancer. Cell. 1991;66(5):831\u2013834. doi: 10.1016/0092-8674(91)90428-2.", "ArticleIdList": ["10.1016/0092-8674(91)90428-2", "1889087"]}, {"Citation": "Ng AP, Loughran SJ, Metcalf D, Hyland CD, de Graaf CA, Hu Y, et al. Erg is required for self-renewal of hematopoietic stem cells during stress hematopoiesis in mice. Blood. 2011;118(9):2454\u20132461. doi: 10.1182/blood-2011-03-344739.", "ArticleIdList": ["10.1182/blood-2011-03-344739", "21673349"]}, {"Citation": "Ma Y, Xu B, Yu J, et al. Fli-1 activation through targeted promoter activity regulation using a novel 3\u2032, 5\u2032-diprenylated chalcone inhibits growth and metastasis of prostate cancer cells. Int J Mol Sci. 2020;21(6):2216. doi: 10.3390/ijms21062216.", "ArticleIdList": ["10.3390/ijms21062216", "PMC7139342", "32210104"]}, {"Citation": "Deveaux S, Filipe A, Lemarchandel V, et al. Analysis of the thrombopoietin receptor (MPL) promoter implicates GATA and Ets proteins in the coregulation of megakaryocyte-specific genes. Blood. 1996;87:4678\u20134685. doi: 10.1182/blood.V87.11.4678.bloodjournal87114678.", "ArticleIdList": ["10.1182/blood.V87.11.4678.bloodjournal87114678", "8639837"]}, {"Citation": "Athanasiou M, Clausen PA, Mavrothalassitis GJ, et al. Increased expression of the ETS-related transcription factor FLI-1/ERGB correlates with and can induce the megakaryocytic phenotype. Cell Growth Differ. 1996;7:1525\u20131534.", "ArticleIdList": ["8930402"]}, {"Citation": "Bastian LS, Kwiatkowski BA, Breininger J, et al. Regulation of the megakaryocytic glycoprotein IX promoter by the oncogenic Ets transcription factor Fli-1. Blood. 1999;93:2637\u20132644. doi: 10.1182/blood.V93.8.2637.", "ArticleIdList": ["10.1182/blood.V93.8.2637", "10194443"]}, {"Citation": "Raslova H, Komura E, Le Couedic JP, et al. FLI1 monoallelic expression combined with its hemizygous loss underlies Paris-Trousseau/Jacobsen thrombopenia. J Clin Investig. 2004;114:77\u201384. doi: 10.1172/JCI21197.", "ArticleIdList": ["10.1172/JCI21197", "PMC437972", "15232614"]}, {"Citation": "Stockley J, Morgan NV, Bem D, et al. Enrichment of FLI1 and RUNX1 mutations in families with excessive bleeding and platelet dense granule secretion defects. Blood. 2013;122:4090\u20134093. doi: 10.1182/blood-2013-06-506873.", "ArticleIdList": ["10.1182/blood-2013-06-506873", "PMC3862284", "24100448"]}, {"Citation": "Krishnamurti L, Neglia JP, Nagarajan R, et al. Paris-Trousseau syndrome platelets in a child with Jacobsen's syndrome. Am J Hematol. 2001;66:295\u2013299. doi: 10.1002/ajh.1061.", "ArticleIdList": ["10.1002/ajh.1061", "11279643"]}, {"Citation": "Klimchenko O, Mori M, Distefano A, et al. A common bipotent progenitor generates the erythroid and megakaryocyte lineages in embryonic stem cell-derived primitive hematopoiesis. Blood. 2009;114:1506\u20131517. doi: 10.1182/blood-2008-09-178863.", "ArticleIdList": ["10.1182/blood-2008-09-178863", "19478046"]}, {"Citation": "Siripin D, Kheolamai P, U-Pratya Y, et al. Transdifferentiation of erythroblasts to megakaryocytes using FLI1 and ERG transcription factors. Thromb Haemost. 2015;114:593\u2013602. doi: 10.1160/TH14-12-1090.", "ArticleIdList": ["10.1160/TH14-12-1090", "26063314"]}, {"Citation": "Moreau T, Evans AL, Vasquez L, et al. Corrigendum: Large-scale production of megakaryocytes from human pluripotent stem cells by chemically defined forward programming. Nat Commun. 2016;8:15076. doi: 10.1038/ncomms11208.", "ArticleIdList": ["10.1038/ncomms11208", "PMC5537628", "28752836"]}, {"Citation": "Dalby A, Ballester-Beltran J, Lincetto C, et al. Transcription factor levels after forward programming of human pluripotent stem cells with GATA1, FLI1, and TAL1 determine megakaryocyte versus erythroid cell fate decision. Stem cell reports. 2018;11:1462\u20131478. doi: 10.1016/j.stemcr.2018.11.001.", "ArticleIdList": ["10.1016/j.stemcr.2018.11.001", "PMC6294717", "30503262"]}, {"Citation": "Huang H, Yu M, Akie TE, et al. Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development. Mol Cell Biol. 2009;29:4103\u20134115. doi: 10.1128/MCB.00090-09.", "ArticleIdList": ["10.1128/MCB.00090-09", "PMC2715817", "19470763"]}, {"Citation": "Tijssen MR, Cvejic A, Joshi A, et al. Genome-wide analysis of simultaneous GATA1/2, RUNX1, FLI1, and SCL binding in megakaryocytes identifies hematopoietic regulators. Dev Cell. 2011;20:597\u2013609. doi: 10.1016/j.devcel.2011.04.008.", "ArticleIdList": ["10.1016/j.devcel.2011.04.008", "PMC3145975", "21571218"]}, {"Citation": "Palii CG, Cheng Q, Gillespie MA, et al. Single-cell proteomics reveal that quantitative changes in co-expressed lineage-specific transcription factors determine cell fate. Cell Stem Cell. 2019;24:812\u2013820.e5. doi: 10.1016/j.stem.2019.02.006.", "ArticleIdList": ["10.1016/j.stem.2019.02.006", "PMC6886472", "30880026"]}, {"Citation": "Soler E, Andrieu-Soler C, de Boer E, et al. The genome-wide dynamics of the binding of Ldb1 complexes during erythroid differentiation. Genes Dev. 2010;24(3):277\u2013289. doi: 10.1101/gad.551810.", "ArticleIdList": ["10.1101/gad.551810", "PMC2811829", "20123907"]}, {"Citation": "Li L, Freudenberg J, Cui K, et al. Ldb1-nucleated transcription complexes function as primary mediators of global erythroid gene activation. Blood. 2013;121(22):4575\u20134585. doi: 10.1182/blood-2013-01-479451.", "ArticleIdList": ["10.1182/blood-2013-01-479451", "PMC3668490", "23610375"]}, {"Citation": "Giraud G, Kolovos P, Boltsis I, et al. Interplay between FLI-1 and the LDB1 complex in murine erythroleukemia cells and during megakaryopoiesis. iScience. 2021;24(3):102210. doi: 10.1016/j.isci.2021.102210.", "ArticleIdList": ["10.1016/j.isci.2021.102210", "PMC7940982", "33733070"]}, {"Citation": "Shivdasani RA, Rosenblatt MF, Zucker-Franklin D, et al. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell. 1995;81:695\u2013704. doi: 10.1016/0092-8674(95)90531-6.", "ArticleIdList": ["10.1016/0092-8674(95)90531-6", "7774011"]}, {"Citation": "Rost MS, Shestopalov I, Liu Y, et al. Nfe2 is dispensable for early but required for adult thrombocyte formation and function in zebrafish. Blood Adv. 2018;2:3418\u20133427. doi: 10.1182/bloodadvances.2018021865.", "ArticleIdList": ["10.1182/bloodadvances.2018021865", "PMC6290098", "30504234"]}, {"Citation": "Wang C, Sample KM, Gajendran B, Kapranov P, Liu W, Hu A, et al. FLI1 induces megakaryopoiesis gene expression through WAS/WIP-dependent and independent mechanisms; implications for Wiskott-Aldrich syndrome. Front Immunol. 2021;12:607836. doi: 10.3389/fimmu.2021.607836.", "ArticleIdList": ["10.3389/fimmu.2021.607836", "PMC7953068", "33717090"]}, {"Citation": "Bosticardo M, Marangoni F, Aiuti A, Villa A, Grazia RM. Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome. Blood. 2009;113(25):6288\u20136295. doi: 10.1182/blood-2008-12-115253.", "ArticleIdList": ["10.1182/blood-2008-12-115253", "19351959"]}, {"Citation": "Pereira R, Quang CT, Lesault I, et al. FLI-1 inhibits differentiation and induces proliferation of primary erythroblasts. Oncogene. 1999;18:1597\u20131608. doi: 10.1038/sj.onc.1202534.", "ArticleIdList": ["10.1038/sj.onc.1202534", "10102630"]}, {"Citation": "Tamir A, Howard J, Higgins RR, et al. Fli-1, an Ets-related transcription factor, regulates erythropoietin-induced erythroid proliferation and differentiation: evidence for direct transcriptional repression of the Rb gene during differentiation. Mol Cell Biol. 1999;19:4452\u20134464. doi: 10.1128/MCB.19.6.4452.", "ArticleIdList": ["10.1128/MCB.19.6.4452", "PMC104404", "10330185"]}, {"Citation": "Minas TZ, Han J, Javaheri T, Hong SH, Schlederer M, Saygide\u011fer-Kont Y, et al. YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model. Oncotarget. 2015;6(35):37678\u201337694. doi: 10.18632/oncotarget.5520.", "ArticleIdList": ["10.18632/oncotarget.5520", "PMC4741957", "26462019"]}, {"Citation": "Spyropoulos DD, Pharr PN, Lavenburg KR, et al. Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor. Mol Cell Biol. 2000;20:5643\u20135652. doi: 10.1128/MCB.20.15.5643-5652.2000.", "ArticleIdList": ["10.1128/MCB.20.15.5643-5652.2000", "PMC86032", "10891501"]}, {"Citation": "Zhang XK, Moussa O, LaRue A, et al. The transcription factor Fli-1 modulates marginal zone and follicular B cell development in mice. J Immunol. 2008;181:1644\u20131654. doi: 10.4049/jimmunol.181.3.1644.", "ArticleIdList": ["10.4049/jimmunol.181.3.1644", "PMC2504761", "18641300"]}, {"Citation": "Zochodne B, Truong AH, Stetler K, et al. Epo regulates erythroid proliferation and differentiation through distinct signaling pathways: implication for erythropoiesis and Friend virus-induced erythroleukemia. Oncogene. 2000;19:2296\u20132304. doi: 10.1038/sj.onc.1203590.", "ArticleIdList": ["10.1038/sj.onc.1203590", "10822380"]}, {"Citation": "Starck J, Weiss-Gayet M, Gonnet C, et al. Inducible Fli-1 gene deletion in adult mice modifies several myeloid lineage commitment decisions and accelerates proliferation arrest and terminal erythrocytic differentiation. Blood. 2010;116:4795\u20134805. doi: 10.1182/blood-2010-02-270405.", "ArticleIdList": ["10.1182/blood-2010-02-270405", "20733157"]}, {"Citation": "Athanasiou M, Mavrothalassitis G, Sun-Hoffman L, et al. FLI-1 is a suppressor of erythroid differentiation in human hematopoietic cells. Leukemia. 2000;14:439\u2013445. doi: 10.1038/sj.leu.2401689.", "ArticleIdList": ["10.1038/sj.leu.2401689", "10720139"]}, {"Citation": "Rekhtman N, Radparvar F, Evans T, et al. Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells. Genes Dev. 1999;13:1398\u20131411. doi: 10.1101/gad.13.11.1398.", "ArticleIdList": ["10.1101/gad.13.11.1398", "PMC316770", "10364157"]}, {"Citation": "Eisbacher M, Holmes ML, Newton A, et al. Protein-protein interaction between Fli-1 and GATA-1 mediates synergistic expression of megakaryocyte-specific genes through cooperative DNA binding. Mol Cell Biol. 2003;23:3427\u20133441. doi: 10.1128/MCB.23.10.3427-3441.2003.", "ArticleIdList": ["10.1128/MCB.23.10.3427-3441.2003", "PMC154245", "12724402"]}, {"Citation": "Fujiwara Y, Browne CP, Cunniff K, et al. Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc Natl Acad Sci USA. 1996;93:12355\u201312358. doi: 10.1073/pnas.93.22.12355.", "ArticleIdList": ["10.1073/pnas.93.22.12355", "PMC37995", "8901585"]}, {"Citation": "Jagadeeswaran P, Lin S, Weinstein B, et al. Loss of GATA1 and gain of FLI1 expression during thrombocyte maturation. Blood Cells Mol Dis. 2010;44:175\u2013180. doi: 10.1016/j.bcmd.2009.12.012.", "ArticleIdList": ["10.1016/j.bcmd.2009.12.012", "PMC2829368", "20110178"]}, {"Citation": "Frontelo P, Manwani D, Galdass M, et al. Novel role for EKLF in megakaryocyte lineage commitment. Blood. 2007;110:3871\u20133880. doi: 10.1182/blood-2007-03-082065.", "ArticleIdList": ["10.1182/blood-2007-03-082065", "PMC2190608", "17715392"]}, {"Citation": "Perkins AC, Sharpe AH, Orkin SH. Lethal beta-thalassaemia in mice lacking the erythroid CACCC-transcription factor EKLF. Nature. 1995;375:318\u2013322. doi: 10.1038/375318a0.", "ArticleIdList": ["10.1038/375318a0", "7753195"]}, {"Citation": "Singleton BK, Burton NM, Green C, et al. Mutations in EKLF/KLF1 form the molecular basis of the rare blood group In(Lu) phenotype. Blood. 2008;112:2081\u20132088. doi: 10.1182/blood-2008-03-145672.", "ArticleIdList": ["10.1182/blood-2008-03-145672", "18487511"]}, {"Citation": "Tallack MR, Perkins AC. Megakaryocyte-erythroid lineage promiscuity in EKLF null mouse blood. Haematologica. 2010;95:144\u2013147. doi: 10.3324/haematol.2009.010017.", "ArticleIdList": ["10.3324/haematol.2009.010017", "PMC2805734", "19850899"]}, {"Citation": "Starck J, Cohet N, Gonnet C, et al. Functional cross-antagonism between transcription factors FLI-1 and EKLF. Mol Cell Biol. 2003;23:1390\u20131402. doi: 10.1128/MCB.23.4.1390-1402.2003.", "ArticleIdList": ["10.1128/MCB.23.4.1390-1402.2003", "PMC141137", "12556498"]}, {"Citation": "Bouilloux F, Juban G, Cohet N, et al. EKLF restricts megakaryocytic differentiation at the benefit of erythrocytic differentiation. Blood. 2008;112:576\u2013584. doi: 10.1182/blood-2007-07-098996.", "ArticleIdList": ["10.1182/blood-2007-07-098996", "18523154"]}, {"Citation": "Svenson JL, Chike-Harris K, Amria MY, et al. The mouse and human Fli1 genes are similarly regulated by Ets factors in T cells. Genes Immun. 2010;11(2):161\u2013172. doi: 10.1038/gene.2009.73.", "ArticleIdList": ["10.1038/gene.2009.73", "PMC2832078", "19829305"]}, {"Citation": "Melet F, Motro B, Rossi DJ, et al. Generation of a novel Fli-1 protein by gene targeting leads to a defect in thymus development and a delay in Friend virus-induced erythroleukemia. Mol Cell Biol. 1996;16:2708\u20132718. doi: 10.1128/MCB.16.6.2708.", "ArticleIdList": ["10.1128/MCB.16.6.2708", "PMC231261", "8649378"]}, {"Citation": "Zhang L, Eddy A, Teng YT, et al. An immunological renal disease in transgenic mice that overexpress Fli-1, a member of the ets family of transcription factor genes. Mol Cell Biol. 1995;15:6961\u20136970. doi: 10.1128/MCB.15.12.6961.", "ArticleIdList": ["10.1128/MCB.15.12.6961", "PMC230951", "8524263"]}, {"Citation": "Smeets MF, Chan AC, Dagger S, et al. Fli-1 overexpression in hematopoietic progenitors deregulates T cell development and induces pre-T cell lymphoblastic leukaemia/lymphoma. PLoS ONE. 2013;8:e62346. doi: 10.1371/journal.pone.0062346.", "ArticleIdList": ["10.1371/journal.pone.0062346", "PMC3646842", "23667468"]}, {"Citation": "Smeets MF, Wiest DL, Izon DJ. Fli-1 regulates the DN2 to DN3 thymocyte transition and promotes gammadelta T-cell commitment by enhancing TCR signal strength. Eur J Immunol. 2014;44:2617\u20132624. doi: 10.1002/eji.201444442.", "ArticleIdList": ["10.1002/eji.201444442", "PMC5242326", "24935715"]}, {"Citation": "Chen Z, Arai E, Khan O, Zhang Z, Ngiow SF, He Y, et al. In vivo CD8+ T cell CRISPR screening reveals control by Fli1 in infection and cancer. Cell. 2021;184(5):1262\u20131280.e22. doi: 10.1016/j.cell.2021.02.019.", "ArticleIdList": ["10.1016/j.cell.2021.02.019", "PMC8054351", "33636129"]}, {"Citation": "Hodge DR, Li D, Qi SM, Farrar WL. IL-6 induces expression of the Fli-1 proto-oncogene via STAT3. Biochem Biophys Res Commun. 2002;292(1):287\u2013291. doi: 10.1006/bbrc.2002.6652.", "ArticleIdList": ["10.1006/bbrc.2002.6652", "11890706"]}, {"Citation": "Lennard Richard ML, Nowling TK, Brandon D, Watson DK, Zhang XK. Fli-1 controls transcription from the MCP-1 gene promoter, which may provide a novel mechanism for chemokine and cytokine activation. Mol Immunol. 2015;63(2):566\u2013573. doi: 10.1016/j.molimm.2014.07.013.", "ArticleIdList": ["10.1016/j.molimm.2014.07.013", "PMC4254164", "25108845"]}, {"Citation": "Lennard Richard ML, Sato S, Suzuki E, Williams S, Nowling TK, Zhang XK. The Fli-1 transcription factor regulates the expression of CCL5/RANTES. J Immunol. 2014;193(6):2661\u20132668. doi: 10.4049/jimmunol.1302779.", "ArticleIdList": ["10.4049/jimmunol.1302779", "PMC4157095", "25098295"]}, {"Citation": "Lennard Richard ML, Brandon D, Lou N, Sato S, Caldwell T, Nowling TK, et al. Acetylation impacts Fli-1-driven regulation of granulocyte colony stimulating factor. Eur J Immunol. 2016;46(10):2322\u20132332. doi: 10.1002/eji.201646315.", "ArticleIdList": ["10.1002/eji.201646315", "PMC5175580", "27431361"]}, {"Citation": "Lou N, Lennard Richard ML, Yu J, Brandon M, Zhang XK. The Fli-1 transcription factor is a critical regulator for controlling the expression of chemokine C-X-C motif ligand 2 (CXCL2) Mol Immunol. 2017;81:59\u201366. doi: 10.1016/j.molimm.2016.11.007.", "ArticleIdList": ["10.1016/j.molimm.2016.11.007", "27889620"]}, {"Citation": "Li P, Goodwin AJ, Cook JA, Halushka PV, Zhang XK, Fan H. Fli-1 transcription factor regulates the expression of caspase-1 in lung pericytes. Mol Immunol. 2019;108:1\u20137. doi: 10.1016/j.molimm.2019.02.003.", "ArticleIdList": ["10.1016/j.molimm.2019.02.003", "PMC6409192", "30739075"]}, {"Citation": "Wang X, Lennard Richard M, Li P, Henry B, Schutt S, Yu XZ, et al. Expression of GM-CSF is regulated by Fli-1 transcription factor, a potential drug target. J Immunol. 2021;206(1):59\u201366. doi: 10.4049/jimmunol.2000664.", "ArticleIdList": ["10.4049/jimmunol.2000664", "PMC7942804", "33268481"]}, {"Citation": "Wang X, Oates JC, Helke KL, Gilkeson GS, Zhang XK. Camptothecin and topotecan, inhibitors of transcription factor Fli-1 and topoisomerase, markedly ameliorate lupus nephritis in NZBWF1 mice and reduce the production of inflammatory mediators in human renal cells. Arthritis Rheumatol. 2021;73(8):1478\u20131488. doi: 10.1002/art.41685.", "ArticleIdList": ["10.1002/art.41685", "PMC9853877", "33559345"]}, {"Citation": "Suzuki E, Williams S, Sato S, et al. The transcription factor Fli-1 regulates monocyte, macrophage and dendritic cell development in mice. Immunology. 2013;139:318\u2013327. doi: 10.1111/imm.12070.", "ArticleIdList": ["10.1111/imm.12070", "PMC3701178", "23320737"]}, {"Citation": "Masuya M, Moussa O, Abe T, et al. Dysregulation of granulocyte, erythrocyte, and NK cell lineages in Fli-1 gene-targeted mice. Blood. 2005;105:95\u2013102. doi: 10.1182/blood-2003-12-4345.", "ArticleIdList": ["10.1182/blood-2003-12-4345", "15367440"]}, {"Citation": "Starck J, Mouchiroud G, Gonnet C, et al. Unexpected and coordinated expression of Spi-1, Fli-1, and megakaryocytic genes in four Epo-dependent cell lines established from transgenic mice displaying erythroid-specific expression of a thermosensitive SV40 T antigen. Exp Hematol. 1999;27:630\u2013641. doi: 10.1016/s0301-472x(99)00006-5.", "ArticleIdList": ["10.1016/s0301-472x(99)00006-5", "10210321"]}, {"Citation": "Kennedy M, Firpo M, Choi K, et al. A common precursor for primitive erythropoiesis and definitive haematopoiesis. Nature. 1997;386(6624):488\u2013493. doi: 10.1038/386488a0.", "ArticleIdList": ["10.1038/386488a0", "9087406"]}, {"Citation": "Huber TL, Kouskoff V, Fehling HJ, et al. Haemangioblast commitment is initiated in the primitive streak of the mouse embryo. Nature. 2004;432(7017):625\u2013630. doi: 10.1038/nature03122.", "ArticleIdList": ["10.1038/nature03122", "15577911"]}, {"Citation": "Iwafuchi-Doi M, Zaret KS. Cell fate control by pioneer transcription factors. Development. 2016;143(11):1833\u20131837. doi: 10.1242/dev.133900.", "ArticleIdList": ["10.1242/dev.133900", "PMC6514407", "27246709"]}, {"Citation": "Wilson NK, Foster SD, Wang X, et al. Combinatorial transcriptional control in blood stem/progenitor cells: genome-wide analysis of ten major transcriptional regulators. Cell Stem Cell. 2010;7(4):532\u2013544. doi: 10.1016/j.stem.2010.07.016.", "ArticleIdList": ["10.1016/j.stem.2010.07.016", "20887958"]}, {"Citation": "Bergiers I, Andrews T, Vargel B\u00f6l\u00fckba\u015f\u0131 \u00d6, et al. Single-cell transcriptomics reveals a new dynamical function of transcription factors during embryonic hematopoiesis. Elife. 2018;7:e29312. doi: 10.7554/eLife.29312.", "ArticleIdList": ["10.7554/eLife.29312", "PMC5860872", "29555020"]}, {"Citation": "Azimi A, Tuominen R, Costa Svedman F, Caramuta S, Pernemalm M, Frostvik Stolt M, et al. Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells. Cell Death Dis. 2017;8(8):e3029. doi: 10.1038/cddis.2017.406.", "ArticleIdList": ["10.1038/cddis.2017.406", "PMC5596587", "29048432"]}, {"Citation": "Paulo P, Barros-Silva JD, Ribeiro FR, et al. FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer. Genes Chromosom Cancer. 2012;51:240\u2013249. doi: 10.1002/gcc.20948.", "ArticleIdList": ["10.1002/gcc.20948", "22081504"]}, {"Citation": "Golub TR, Barker GF, Bohlander SK, Hiebert SW, Ward DC, Bray-Ward P, et al. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci USA. 1995;92(11):4917\u20134921. doi: 10.1073/pnas.92.11.4917.", "ArticleIdList": ["10.1073/pnas.92.11.4917", "PMC41818", "7761424"]}, {"Citation": "Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science. 2005;310(5748):644\u2013648. doi: 10.1126/science.1117679.", "ArticleIdList": ["10.1126/science.1117679", "16254181"]}, {"Citation": "Tomlins SA, Mehra R, Rhodes DR, Smith LR, Roulston D, Helgeson BE, et al. TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer. Cancer Res. 2006;66(7):3396\u20133400. doi: 10.1158/0008-5472.CAN-06-0168.", "ArticleIdList": ["10.1158/0008-5472.CAN-06-0168", "16585160"]}, {"Citation": "Helgeson BE, Tomlins SA, Shah N, Laxman B, Cao Q, Prensner JR, et al. Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer. Cancer Res. 2008;68(1):73\u201380. doi: 10.1158/0008-5472.CAN-07-5352.", "ArticleIdList": ["10.1158/0008-5472.CAN-07-5352", "18172298"]}, {"Citation": "Rickman DS, Pflueger D, Moss B, VanDoren VE, Chen CX, de la Taille A, Kuefer R, Tewari AK, Setlur SR, Demichelis F, Rubin MA. SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer. Cancer Res. 2009;69(7):2734\u20132738. doi: 10.1158/0008-5472.CAN-08-4926.", "ArticleIdList": ["10.1158/0008-5472.CAN-08-4926", "PMC4063441", "19293179"]}, {"Citation": "Bonetti P, Testoni M, Scandurra M, Ponzoni M, Piva R, Mensah AA, Rinaldi A, Kwee I, Tibiletti MG, Iqbal J, Greiner TC, Chan WC, et al. Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma. Blood. 2013;122(13):2233\u20132241. doi: 10.1182/blood-2013-01-475772.", "ArticleIdList": ["10.1182/blood-2013-01-475772", "23926301"]}, {"Citation": "Mesquita B, Lopes P, Rodrigues A, Pereira D, Afonso M, Leal C, Henrique R, Lind GE, Jer\u00f3nimo C, Lothe RA, Teixeira MR. Frequent copy number gains at 1q21 and 1q32 are associated with overexpression of the ETS transcription factors ETV3 and ELF3 in breast cancer irrespective of molecular subtypes. Breast Cancer Res Treat. 2013;138(1):37\u201345. doi: 10.1007/s10549-013-2408-2.", "ArticleIdList": ["10.1007/s10549-013-2408-2", "23329352"]}, {"Citation": "Zhang J, McCastlain K, Yoshihara H, Xu B, Chang Y, Churchman ML, Wu G, Li Y, Wei L, Iacobucci I, et al. Deregulation of DUX4 and ERG in acute lymphoblastic leukemia. Nat Genet. 2016;48(12):1481\u20131489. doi: 10.1038/ng.3691.", "ArticleIdList": ["10.1038/ng.3691", "PMC5144107", "27776115"]}, {"Citation": "Ando M, Kawazu M, Ueno T, Koinuma D, Ando K, Koya J, Kataoka K, Yasuda T, Yamaguchi H, Fukumura K, et al. Mutational landscape and antiproliferative functions of ELF transcription factors in human cancer. Cancer Res. 2016;76(7):1814\u20131824. doi: 10.1158/0008-5472.CAN-14-3816.", "ArticleIdList": ["10.1158/0008-5472.CAN-14-3816", "26921333"]}, {"Citation": "Lilljebj\u00f6rn H, Henningsson R, Hyrenius-Wittsten A, Olsson L, Orsmark-Pietras C, von Palffy S, Askmyr M, Rissler M, Schrappe M, Cario G, et al. Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia. Nat Commun. 2016;7:11790. doi: 10.1038/ncomms11790.", "ArticleIdList": ["10.1038/ncomms11790", "PMC4897744", "27265895"]}, {"Citation": "Seki M, Kimura S, Isobe T, Yoshida K, Ueno H, Nakajima-Takagi Y, Wang C, Lin L, Kon A, Suzuki H, et al. Recurrent SPI1 (PU.1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia. Nat Genet. 2017;49(8):1274\u20131281. doi: 10.1038/ng.3900.", "ArticleIdList": ["10.1038/ng.3900", "28671687"]}, {"Citation": "Bose R, Karthaus WR, Armenia J, Abida W, Iaquinta PJ, Zhang Z, Wongvipat J, Wasmuth EV, Shah N, Sullivan PS, et al. ERF mutations reveal a balance of ETS factors controlling prostate oncogenesis. Nature. 2017;546(7660):671\u2013675. doi: 10.1038/nature22820.", "ArticleIdList": ["10.1038/nature22820", "PMC5576182", "28614298"]}, {"Citation": "Budka JA, Ferris MW, Capone MJ, Hollenhorst PC. Common ELF1 deletion in prostate cancer bolsters oncogenic ETS function, inhibits senescence and promotes docetaxel resistance. Genes Cancer. 2018;9(5\u20136):198\u2013214. doi: 10.18632/genesandck;ancer.182.", "ArticleIdList": ["10.18632/genesandck;ancer.182", "PMC6305106", "30603056"]}, {"Citation": "Luk IY, Reehorst CM, Mariadason JM. ELF3, ELF5, EHF and SPDEF transcription factors in tissue homeostasis and cancer. Molecules. 2018;23(9):2191. doi: 10.3390/molecules23092191.", "ArticleIdList": ["10.3390/molecules23092191", "PMC6225137", "30200227"]}, {"Citation": "Zaliova M, Potuckova E, Hovorkova L, et al. ERG deletions in childhood acute lymphoblastic leukemia with DUX4 rearrangements are mostly polyclonal, prognostically relevant and their detection rate strongly depends on screening method sensitivity. Haematologica. 2019;104(7):1407\u20131416. doi: 10.3324/haematol.2018.204487.", "ArticleIdList": ["10.3324/haematol.2018.204487", "PMC6601096", "30630977"]}, {"Citation": "Yuan X, Dai M, Xu D. TERT promoter mutations and GABP transcription factors in carcinogenesis: more foes than friends. Cancer Lett. 2020;493:1\u20139. doi: 10.1016/j.canlet.2020.07.003.", "ArticleIdList": ["10.1016/j.canlet.2020.07.003", "32768523"]}, {"Citation": "Montgomery-Goecker C, Koduru P, Botten G, Xu J, Ghisoli M, Goldman SC, et al. Mixed phenotype acute leukemia, b/myeloid (bilineal and biphenotypic), with t(2;22)(q35;q12);EWSR1-FEV. J Pediatr Hematol Oncol. 2021;43(3):e388\u2013e394. doi: 10.1097/MPH.0000000000001934.", "ArticleIdList": ["10.1097/MPH.0000000000001934", "32925408"]}, {"Citation": "Suico MA, Shuto T, Kai H. Roles and regulations of the ETS transcription factor ELF4/MEF. J Mol Cell Biol. 2017;9(3):168\u2013177. doi: 10.1093/jmcb/mjw051.", "ArticleIdList": ["10.1093/jmcb/mjw051", "PMC5907832", "27932483"]}, {"Citation": "Erkizan HV, Kong Y, Merchant M, et al. A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma. Nat Med. 2009;15:750\u2013756. doi: 10.1038/nm.1983.", "ArticleIdList": ["10.1038/nm.1983", "PMC2777681", "19584866"]}, {"Citation": "Grohar PJ, Griffin LB, Yeung C, et al. Ecteinascidin 743 interferes with the activity of EWS-FLI1 in Ewing sarcoma cells. Neoplasia (New York, N.Y.) 2011;13:145\u2013153. doi: 10.1593/neo.101202.", "ArticleIdList": ["10.1593/neo.101202", "PMC3033593", "21403840"]}, {"Citation": "Z\u00f6llner SK, Amatruda JF, Bauer S, et al. Ewing sarcoma-diagnosis, treatment, clinical challenges and future perspectives. J Clin Med. 2021;10(8):1685. doi: 10.3390/jcm10081685.", "ArticleIdList": ["10.3390/jcm10081685", "PMC8071040", "33919988"]}, {"Citation": "Li YJ, Zhao X, Vecchiarelli-Federico LM, et al. Drug-mediated inhibition of Fli-1 for the treatment of leukemia. Blood Cancer J. 2012;2:e54. doi: 10.1038/bcj.2011.52.", "ArticleIdList": ["10.1038/bcj.2011.52", "PMC3270256", "22829238"]}, {"Citation": "Song J, Yuan C, Yang J, et al. Novel flavagline-like compounds with potent Fli-1 inhibitory activity suppress diverse types of leukemia. FEBS J. 2018;285:4631\u20134645. doi: 10.1111/febs.14690.", "ArticleIdList": ["10.1111/febs.14690", "30387554"]}, {"Citation": "Liu T, Xia L, Yao Y, et al. Identification of diterpenoid compounds that interfere with Fli-1 DNA binding to suppress leukemogenesis. Cell Death Dis. 2019;10:117. doi: 10.1038/s41419-019-1363-1.", "ArticleIdList": ["10.1038/s41419-019-1363-1", "PMC6370842", "30741932"]}, {"Citation": "Hou C, Mandal A, Rohr J, Tsodikov OV. Allosteric interference in oncogenic FLI1 and ERG transactions by mithramycins. Structure. 2020;29(5):404\u2013412.e4. doi: 10.1016/j.str.2020.11.012.", "ArticleIdList": ["10.1016/j.str.2020.11.012", "PMC8106648", "33275876"]}, {"Citation": "Rajesh Y, Biswas A, Kumar U, Banerjee I, Das S, Maji S, Das SK, Emdad L, Cavenee WK, Mandal M, Fisher PB. Lumefantrine, an antimalarial drug, reverses radiation and temozolomide resistance in glioblastoma. Proc Natl Acad Sci USA. 2020;117(22):12324\u201312331. doi: 10.1073/pnas.1921531117.", "ArticleIdList": ["10.1073/pnas.1921531117", "PMC7275698", "32409605"]}, {"Citation": "Yao Y, Liu W, Gajendran B, Wang C, Zacksenhaus E, Sample KM, Varier KM, Hao X, Ben-David Y. Ubash3b promotes TPA-mediated suppression of leukemogenesis through accelerated downregulation of PKC\u03b4 protein. Biochimie. 2021;184:8\u201317. doi: 10.1016/j.biochi.2021.02.001.", "ArticleIdList": ["10.1016/j.biochi.2021.02.001", "33556471"]}, {"Citation": "Mora-Garcia P, Wei J, Sakamoto KM. G-CSF induces stabilization of ETS protein Fli-1 during myeloid cell development. Pediatr Res. 2005;57(1):63\u201366. doi: 10.1203/01.PDR.0000147729.55592.2C.", "ArticleIdList": ["10.1203/01.PDR.0000147729.55592.2C", "15557108"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "11", "Day": "1"}, {"Year": "2022", "Month": "1", "Day": "19"}, {"Year": "2022", "Month": "1", "Day": "5"}, {"Year": "2022", "Month": "4", "Day": "12", "Hour": "12", "Minute": "5"}, {"Year": "2022", "Month": "4", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "4", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "28"}], "PublicationStatus": "epublish", "ArticleIdList": ["35412146", "PMC11072361", "10.1007/s00018-022-04160-1", "10.1007/s00018-022-04160-1"]}}], "PubmedBookArticle": []}